STAAR Surgical Net Income/Loss 2010-2024 | STAA
STAAR Surgical net income/loss from 2010 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
| STAAR Surgical Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $-20 |
| 2023 | $21 |
| 2022 | $40 |
| 2021 | $28 |
| 2020 | $6 |
| 2019 | $14 |
| 2018 | $5 |
| 2017 | $-2 |
| 2016 | $-12 |
| 2015 | $-7 |
| 2014 | $-8 |
| 2013 | $0 |
| 2012 | $-2 |
| 2011 | $1 |
| 2010 | $0 |
| 2009 | $-6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.833B | $0.314B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $87.363B | 23.91 |
| Becton Dickinson (BDX) | United States | $57.057B | 14.28 |
| Cardinal Health (CAH) | United States | $32.542B | 17.43 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.704B | 0.00 |
| Labcorp (LH) | United States | $18.166B | 14.90 |
| Cooper (COO) | United States | $15.901B | 21.09 |
| West Pharmaceutical Services (WST) | United States | $14.596B | 29.91 |
| Align Technology (ALGN) | United States | $12.549B | 24.31 |
| Henry Schein (HSIC) | United States | $7.930B | 13.66 |
| Merit Medical Systems (MMSI) | United States | $5.369B | 26.12 |
| Patterson (PDCO) | United States | $2.772B | 15.98 |
| DENTSPLY SIRONA (XRAY) | United States | $2.557B | 7.68 |
| CONMED (CNMD) | United States | $1.503B | 11.68 |
| Pro-Dex (PDEX) | United States | $0.198B | 30.26 |
| Lifevantage (LFVN) | United States | $0.169B | 18.65 |